Role of angiotensin II and angiotensin-(1-7) in diabetes-induced oxidative DNA damage in the corpus cavernosum

Fertility and Sterility

Volumn 100, Issue 1, 2013, Pages 226-233

  Kilarkaje, Narayana ^a   Yousif, Mariam H M ^a   El Hashim, Ahmed Z ^a   Makki, Batoul ^a   Akhtar, Saghir ^a   Benter, Ibrahim F ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

ACE inhibitors; angiotensin (1 7); AT1 receptor blockers; DNA damage; Erectile dysfunction; renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN[1-7]; CAPTOPRIL; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; CYTOPLASM; DIABETES MELLITUS; DNA DAMAGE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; UPREGULATION;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; MALE; OXIDATIVE STRESS; PENIS; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84879695154     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.02.046     Document Type: Article

References (53)

1. P.P. Toth Effective management of the type 2 diabetes patient with cardiovascular and renal disease: secondary prevention strategies after a myocardial infarction Curr Diabetes Rev 8 2012 219 228
2. D. Price Sexual function in men and women with diabetes R. Holt, Textbook of diabetes 4th ed. 2010 Blackwell Publishing Oxford, UK 743 759
3. L.S. Hakim, and I. Goldstein Diabetic sexual dysfunction Endocrinol Metab Clin North Am 25 1996 379 400
4. I. Goldstein, J.M. Young, J. Fischer, K. Bangerter, T. Segerson, T. Taylor Vardenafil Diabetes Study Group Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study Diabete Care 26 2003 777 783
5. G. Lowe, and R.A. Costabile 10-Year analysis of adverse event reports to the Food and Drug Administration for phosphodiesterase type-5 inhibitors J Sex Med 9 2012 265 270
6. S. Amaral, P.J. Oliveira, and R.A. Santos Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species J Curr Diabetes Rev 4 2008 46 54
7. A. Tuncayengin, H. Biri, M. Onaran, I. Sen, O. Tuncayengin, and F. Polat Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction Int J Androl 26 2003 250 254
8. T.J. Bivalacqua, B. Musicki, M.F. Usta, H.C. Champion, P.J. Kadowitz, and A.L. Burnett Endothelial nitric oxide synthase gene therapy for erectile dysfunction Curr Pharm Des 11 2005 4059 4067
9. A. Keegan, M.A. Cotter, and N.E. Cameron Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats Diabetologia 42 1999 343 350
10. L. De Young, D. Yu, R.M. Bateman, and G.B. Brock Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction J Androl 25 2004 830 836
11. U.M. Steckelings, F. Rompe, E. Kaschina, and T. Unger The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets Fundam Clin Pharmacol 23 2009 693 703
12. J. Yang, Y. Tan, F. Zhao, Z. Ma, Y. Wang, and S. Zheng Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage Am J Physiol Endocrinol Metab 301 2011 E132 E144
13. D. Yavuz, B. Küçükkaya, G. Haklar, O. Ersöz, E. Akoǧlu, and S. Akalin Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney Prostaglandins Leukot Essent Fatty Acids 69 2003 223 227
14. K. Park, J.W. Shin, J.K. Oh, K.S. Ryu, S.W. Kim, and J.S. Paick Restoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1 J Androl 26 2005 123 128
15. R.A. Santos, A.C. Simoes e Silva, C. Maric, D.M. Silva, R.P. Machado, and I. de Buhr Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proc Natl Acad Sci U S A 100 2003 8258 8263
16. M.T. Abdel Aziz, M.F. el Asmer, T. Mostafa, H. Atta, S. Mahfouz, and H. Fouad Effects of losartan, HO-1 inducers or HO-1 inhibitors on erectile signaling in diabetic rats J Sex Med 6 2009 3254 3264
17. I.F. Benter, D.I. Diz, and C.M. Ferrario Cardiovascular actions of angiotensin-(1-7) Peptides 14 1993 679 684
18. I.F. Benter, C.M. Ferrario, M. Morris, and D.I. Diz Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats Am J Physiol 269 1995 H313 H319
19. C.M. Ferrario, S. Ahmad, J. Joyner, and J. Varagic Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7) Adv Pharmacol 59 2010 197 233
20. R.A. Santos, A.J. Ferreira, T. Verano-Braga, and M. Bader Angiotensin-converting enzyme 2, Angiotensin-(1-7) and Mas: new players of the renin angiotensin system J Endocrinol 216 2013 R1 17
21. I.F. Benter, M.H. Yousif, J.T. Anim, C. Cojocel, and D.I. Diz Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME Am J Physiol Heart Circ Physiol 290 2006 H684 H691
22. I.F. Benter, M.H. Yousif, C. Cojocel, M. Al-Maghrebi, and D.I. Diz Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction Am J Physiol Heart Circ Physiol 292 2007 H666 H672
23. M. Al-Maghrebi, I.F. Benter, and D.I. Diz Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats Pharmacol Res 59 2009 263 268
24. L.A. Rabelo, N. Alenina, and M. Bader ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease Hypertens Res 34 2011 154 160
25. A.Z. El-Hashim, W.M. Renno, R. Raghupathy, H.T. Abduo, S. Akhtar, and I.F. Benter Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways Br J Pharmacol 166 2012 1964 1976
26. A.C. da Costa-Goncalves, R.A Fraga-Silva, R. Leite, and R.A. Santos AVE 0991, a non-peptide Mas-receptor agonist, facilitates penile erection Exp Physiol 98 2013 850 855
27. I.F. Benter, M.H. Yousif, G.S. Dhaunsi, J. Kaur, M.C. Chappell, and D.I. Diz Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats Am J Nephrol 28 2008 25 33
28. M.H. Yousif, G.S. Dhaunsi, B.M. Makki, B.A. Qabazard, S. Akhtar, and I.F. Benter Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes Pharmacol Res 66 2011 269 275
29. A.C. Da Costa Gonçalves, R. Leite, R.A. Fraga-Silva, S.V. Pinheiro, A.B. Reis, and F.M. Reis Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function Am J Physiol Heart Circ Physiol 293 2007 H2588 H2596
30. M.H.M. Yousif, E.O. Kehinde, and I.F. Benter Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum Pharmacol Res 56 2007 209 216
31. Bancroft JD, Stevens A. Theory and practice of histological techniques. Banchroft JD, ed. 3rd ed. London: Churchill Livingstone, 1990:133-4, 188.
32. K. Narayana Cisplatin induces duplex 3' overhangs and 5' blunt ends in epididymal epithelium in a Bax-dependent manner without any protection from L-ascorbic acid Eur J Pharmacol 641 2010 238 245
33. K. Narayana, and R. Raghupathy DNA damage in lead-exposed hepatocytes: Coexistence of apoptosis and necrosis? Drug Chem Toxicol 35 2012 208 217
34. H.R. Jin, W.J. Kim, J.S. Song, M.J. Choi, S. Piao, and S.H. Shin Functional and morphologic characterizations of the diabetic mouse corpus cavernosum: comparison of a multiple low-dose and a single high-dose streptozotocin protocols J Sex Med 6 2009 3289 3304
35. A.Y. Wei, S.H. He, J.F. Zhao, Y. Liu, Y. Liu, and Y.W. Hu Characterization of corpus cavernosum smooth muscle cell phenotype in diabetic rats with erectile dysfunction Int J Impot Res 24 2012 196 201
36. P.T. Koi, P.M. Milhoua, V. Monrose, A. Melman, and M.E. di Santo Expression of myosin isoforms in the smooth muscle of human corpus cavernosum Int J Impot Res 19 2007 62 68
37. J. Angulo, C. Peiró, P. Cuevas, S. Gabancho, A. Fernández, and R. González-Corrochano The novel antioxidant, AC3056 (2,6-di-t-butyl-4-((dimethyl-4-methoxyphenylsilyl) methyloxy) phenol), reverses erectile dysfunction in diabetic rats and improves NO-mediated responses in penile tissue from diabetic men J Sex Med 6 2009 373 387
38. P. Tsounapi, M. Saito, F. Dimitriadis, S. Koukos, S. Shimizu, and K. Satoh Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced testicular dysfunction in the rat Mol Cell Biochem 369 2012 195 204
39. E. Díaz-Díaz, M.C. León, M.O. Arzuaga, C.M. Timossi, R.A.G. Díaz, and C.A. Salinas Erectile dysfunction: a chronic complication of the diabetes mellitus K.P. Nunes, Erectile dysfunction - disease-associated mechanisms and novel insights into therapy 2012 Tech Publishers Croatia 69 96
40. D.E. Barnes, and T. Lindahl Repair and genetic consequences of endogenous DNA base damage in mammalian cells Annu Rev Genet 38 2004 445 476
41. J.L. Evans, E.D. Ira, G.B.A. Maddux, and G.M. Grodsky Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes Endocrinol Rev 23 2002 599 622
42. M. Kamper, O. Tsimpoukidi, A. Chatzigeorgiou, M. Lymberi, and E.F. Kamper The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats Transl Res 156 2010 26 36
43. E.A. Ellis, M.B. Grant, F.T. Murray, M.B. Wachowski, D.L. Guberski, and P.S. Kubilis Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat Free Radic Biol Med 24 1998 111 120
44. S. Sukhanov, L. Semprun-Prieto, T. Yoshida, M.A. Tabony, Y. Higashi, and S. Galvez Angiotensin II, oxidative stress and skeletal muscle wasting Am J Med Sci 342 2011 143 147
45. P. Chen, A.M. Guo, P.A. Edwards, G. Trick, and A.G. Scicli Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis Am J Physiol Regul Integr Comp Physiol 293 2007 R1619 R1629
46. M. Fukumoto, S. Takai, E. Ishizaki, T. Sugiyama, H. Oku, and D. Jin Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model Curr Eye Res 33 2008 885 891
47. I.F. Benter, M.H. Yousif, F.M. Al-Saleh, R. Raghupathy, M.C. Chappell, and D.I. Diz Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester J Cardiovasc Pharmacol 57 2011 559 567
48. N.M. Mordwinkin, C.J. Meeks, S.S. Jadhav, T. Espinoza, N. Roda, and G.S. diZerega Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow Endocrinol 153 2012 2189 2197
49. C. Liu, X.H. Lv, H.X. Li, X. Cao, F. Zhang, and L. Wang Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes Acta Diabetol 49 2012 291 299
50. X. Liao, L. Wang, C. Yang, J. He, X. Wang, and R. Guo Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion- induced injury through the inhibition of oxidative stress Mol Med Report 4 2011 1145 1150
51. S. Akhtar, M.H. Yousif, G.S. Dhaunsi, B. Chandrasekhar, O. Al-Farsi, and I.F. Benter Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway Br J Pharmacol 165 2012 1390 1400
52. J.F. Giani, M.M. Gironacci, M.C. Muñoz, D. Turyn, and F.P. Dominici Angiotensin-(1-7) has a dual role on growth-promoting signaling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity Exp Physiol 93 2008 570 578
53. T.M. Gwathmey, K.D. Pendergrass, S.D. Reid, J.C. Rose, D.I. Diz, and M.C. Chappell Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus Hypertension 55 2010 166 171